Fingerprint
Dive into the research topics of 'Clinical use of dornase alfa is associated with a slower rate of FEV 1 decline in cystic fibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical use of dornase alfa is associated with a slower rate of FEV 1 decline in cystic fibrosis
Michael W. Konstan, Jeffrey S. Wagener, David J. Pasta, Stefanie J. Millar, Joan R. Jacobs, Ashley Yegin, Wayne J. Morgan
Research output: Contribution to journal › Article › peer-review
73
Scopus
citations